|
|
|
|
|
|
|
|
|
|
Expert Commentary on Frequently Asked Questions in Ovarian Cancer
Unraveling the Risks and Benefits of Antiangiogenic Therapy for
Ovarian Cancer Patients
Bradley J. Monk, MD, FACS, FACOG
University of Arizona Cancer Center-Ph
Subscribe to:
Post Comments
(
Atom
)
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.